DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition.

IF 4.1 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Endocrine-related cancer Pub Date : 2023-08-16 Print Date: 2023-10-01 DOI:10.1530/ERC-23-0051
Bilal F Samhouri, Thorvardur R Halfdanarson, Chi Wan Koo, Cormac McCarthy, Eunhee S Yi, Charles F Thomas, Jay H Ryu
{"title":"DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition.","authors":"Bilal F Samhouri,&nbsp;Thorvardur R Halfdanarson,&nbsp;Chi Wan Koo,&nbsp;Cormac McCarthy,&nbsp;Eunhee S Yi,&nbsp;Charles F Thomas,&nbsp;Jay H Ryu","doi":"10.1530/ERC-23-0051","DOIUrl":null,"url":null,"abstract":"<p><p>Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare, but increasingly recognized entity that primarily affects middle-aged and elderly women. It is characterized by abnormal proliferation of pulmonary neuroendocrine cells (PNECs) and is considered a preinvasive lesion for carcinoid tumorlets/tumors. Sometimes, DIPNECH is accompanied by constrictive bronchiolitis which usually manifests as chronic cough and/or dyspnea, along with airflow limitation on spirometry. The telltale imaging sign of DIPNECH is the presence of multiple noncalcified pulmonary nodules and mosaic attenuation on CT. However, these clinico-radiologic features of DIPNECH are characteristic but nonspecific; thus, histopathologic confirmation is usually necessary. DIPNECH has an indolent course and only rarely leads to respiratory failure or death; progression to overt neuroendocrine tumor (carcinoid) of the lung occurs in a minority of patients. Of available therapies, somatostatin analogs and mechanistic target of rapamycin inhibitors are the most promising. In this review, we provide an update regarding the diagnosis and management of DIPNECH and describe critical gaps in our understanding of this entity, including the central terms 'diffuse' and 'idiopathic.' We also summarize the inconsistencies in definitions employed by recent studies and discuss the pitfalls of the DIPNECH definitions proposed by the World Health Organization in 2021. In this context, we propose an objective and reproducible radio-pathologic case definition intended for implementation in the research realm and seeks to enhance homogeneity across cohorts. Furthermore, we discuss aspects of PNECs biology which suggest that PNEC hyperplasia may contribute to the pathogenesis of phenotypes of lung disease aside from constrictive bronchiolitis and carcinoid tumorlets/tumors. Finally, we steer attention to some of the most pressing and impactful research questions awaiting to be unraveled.</p>","PeriodicalId":11654,"journal":{"name":"Endocrine-related cancer","volume":"30 10","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2023-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine-related cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ERC-23-0051","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare, but increasingly recognized entity that primarily affects middle-aged and elderly women. It is characterized by abnormal proliferation of pulmonary neuroendocrine cells (PNECs) and is considered a preinvasive lesion for carcinoid tumorlets/tumors. Sometimes, DIPNECH is accompanied by constrictive bronchiolitis which usually manifests as chronic cough and/or dyspnea, along with airflow limitation on spirometry. The telltale imaging sign of DIPNECH is the presence of multiple noncalcified pulmonary nodules and mosaic attenuation on CT. However, these clinico-radiologic features of DIPNECH are characteristic but nonspecific; thus, histopathologic confirmation is usually necessary. DIPNECH has an indolent course and only rarely leads to respiratory failure or death; progression to overt neuroendocrine tumor (carcinoid) of the lung occurs in a minority of patients. Of available therapies, somatostatin analogs and mechanistic target of rapamycin inhibitors are the most promising. In this review, we provide an update regarding the diagnosis and management of DIPNECH and describe critical gaps in our understanding of this entity, including the central terms 'diffuse' and 'idiopathic.' We also summarize the inconsistencies in definitions employed by recent studies and discuss the pitfalls of the DIPNECH definitions proposed by the World Health Organization in 2021. In this context, we propose an objective and reproducible radio-pathologic case definition intended for implementation in the research realm and seeks to enhance homogeneity across cohorts. Furthermore, we discuss aspects of PNECs biology which suggest that PNEC hyperplasia may contribute to the pathogenesis of phenotypes of lung disease aside from constrictive bronchiolitis and carcinoid tumorlets/tumors. Finally, we steer attention to some of the most pressing and impactful research questions awaiting to be unraveled.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
DIPNECH:务实的方法,不确定性,显著的关联,以及改进定义的建议。
弥漫性特发性肺神经内分泌细胞增生(DIPNECH)是一种罕见但越来越被认可的实体,主要影响中老年妇女。其特征是肺神经内分泌细胞(PNEC)的异常增殖,被认为是类癌/肿瘤的侵袭前病变。有时,DIPNECH伴有收缩性细支气管炎,通常表现为慢性咳嗽和/或呼吸困难,以及肺活量测定的气流限制。DIPNECH的影像学征象是CT上存在多个非钙化肺结节和马赛克衰减。然而,DIPNECH这些临床放射学特征是特征性的,但非特异性;因此,组织病理学的确认通常是必要的。DIPNECH具有惰性过程,很少导致呼吸衰竭或死亡;少数患者会发展为肺部明显的神经内分泌肿瘤(类癌)。在现有的治疗方法中,生长抑素类似物和雷帕霉素抑制剂的机制靶点是最有前景的。在这篇综述中,我们提供了关于DIPNECH诊断和管理的最新信息,并描述了我们对该实体的理解中的关键差距,包括中心术语“弥漫性”和“特发性”我们还总结了最近研究中使用的定义的不一致性,并讨论了世界卫生组织在2021年提出的DIPNECH定义的陷阱。在这种情况下,我们提出了一个客观且可重复的无线电病理病例定义,旨在在研究领域实施,并寻求增强队列之间的同质性。此外,我们还讨论了PNEC生物学的各个方面,这些方面表明,PNEC增生可能有助于除收缩性细支气管炎和类癌小细胞/肿瘤外的肺部疾病表型的发病机制。最后,我们将注意力转移到一些最紧迫、最有影响力的研究问题上,这些问题有待解决。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrine-related cancer
Endocrine-related cancer 医学-内分泌学与代谢
CiteScore
7.80
自引率
2.60%
发文量
138
审稿时长
6-12 weeks
期刊介绍: Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics. Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.
期刊最新文献
Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases GPNMB promotes tumor growth and is a biomarker for lymphangioleiomyomatosis Neuropilin-2 and soluble neuropilin-2 in neuroendocrine neoplasms Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer Genetic disorders and insulinoma/glucagonoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1